Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia

A practical approach to clinical diagnosis

Patricia Aoun, Michele Wiggins, Diane Pickering, James Foran, Husain Rasheed, Steve Z. Pavletic, Warren G Sanger

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Chronic myelogenous leukemia (CML) is characterized by the Philadelphia chromosome (Ph) in more than 90% of cases. Recent studies using fluorescence in situ hybridization (FISH) have shown that in a subset of patients with CML, deletions of 9q34 involving the argininosuccinate synthetase region occur at the time of the Philadelphia translocation and are associated with a poor prognosis. We performed interphase FISH studies in 152 cases of CML using a dual-color, dual-fusion probe system with a third probe directed at 9q34. Cytogenetic studies showed a simple (typical) Ph in 124/152 (82%), a cryptic Ph in 11/152 (7%), and a variant Ph chromosome with a complex translocation in 17/152 (11%) of cases. Interphase FISH studies showed single BCR/ABL fusion patterns in 48/152 (32%) of cases. Deletions of 9q34 were observed in 14% of all the cases and were present in 46% of cases with single BCR/ABL fusion pattern. All the 9q34 deletions occurred in cases with single BCR/ABL fusion signal. However, a single-fusion pattern is not specific for 9q34 deletions, and cases should be routinely screened for the presence of this prognostically significant abnormality by using a third probe directed specifically at 9q34.

Original languageEnglish (US)
Pages (from-to)138-143
Number of pages6
JournalCancer Genetics and Cytogenetics
Volume154
Issue number2
DOIs
StatePublished - Oct 15 2004

Fingerprint

Interphase
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Fluorescence In Situ Hybridization
Argininosuccinate Synthase
Philadelphia Chromosome
Cytogenetics
Color
Chromosomes

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia : A practical approach to clinical diagnosis. / Aoun, Patricia; Wiggins, Michele; Pickering, Diane; Foran, James; Rasheed, Husain; Pavletic, Steve Z.; Sanger, Warren G.

In: Cancer Genetics and Cytogenetics, Vol. 154, No. 2, 15.10.2004, p. 138-143.

Research output: Contribution to journalArticle

Aoun, Patricia ; Wiggins, Michele ; Pickering, Diane ; Foran, James ; Rasheed, Husain ; Pavletic, Steve Z. ; Sanger, Warren G. / Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia : A practical approach to clinical diagnosis. In: Cancer Genetics and Cytogenetics. 2004 ; Vol. 154, No. 2. pp. 138-143.
@article{4ea614e1a57549f1a3c9b890db99404e,
title = "Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: A practical approach to clinical diagnosis",
abstract = "Chronic myelogenous leukemia (CML) is characterized by the Philadelphia chromosome (Ph) in more than 90{\%} of cases. Recent studies using fluorescence in situ hybridization (FISH) have shown that in a subset of patients with CML, deletions of 9q34 involving the argininosuccinate synthetase region occur at the time of the Philadelphia translocation and are associated with a poor prognosis. We performed interphase FISH studies in 152 cases of CML using a dual-color, dual-fusion probe system with a third probe directed at 9q34. Cytogenetic studies showed a simple (typical) Ph in 124/152 (82{\%}), a cryptic Ph in 11/152 (7{\%}), and a variant Ph chromosome with a complex translocation in 17/152 (11{\%}) of cases. Interphase FISH studies showed single BCR/ABL fusion patterns in 48/152 (32{\%}) of cases. Deletions of 9q34 were observed in 14{\%} of all the cases and were present in 46{\%} of cases with single BCR/ABL fusion pattern. All the 9q34 deletions occurred in cases with single BCR/ABL fusion signal. However, a single-fusion pattern is not specific for 9q34 deletions, and cases should be routinely screened for the presence of this prognostically significant abnormality by using a third probe directed specifically at 9q34.",
author = "Patricia Aoun and Michele Wiggins and Diane Pickering and James Foran and Husain Rasheed and Pavletic, {Steve Z.} and Sanger, {Warren G}",
year = "2004",
month = "10",
day = "15",
doi = "10.1016/j.cancergencyto.2004.02.012",
language = "English (US)",
volume = "154",
pages = "138--143",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia

T2 - A practical approach to clinical diagnosis

AU - Aoun, Patricia

AU - Wiggins, Michele

AU - Pickering, Diane

AU - Foran, James

AU - Rasheed, Husain

AU - Pavletic, Steve Z.

AU - Sanger, Warren G

PY - 2004/10/15

Y1 - 2004/10/15

N2 - Chronic myelogenous leukemia (CML) is characterized by the Philadelphia chromosome (Ph) in more than 90% of cases. Recent studies using fluorescence in situ hybridization (FISH) have shown that in a subset of patients with CML, deletions of 9q34 involving the argininosuccinate synthetase region occur at the time of the Philadelphia translocation and are associated with a poor prognosis. We performed interphase FISH studies in 152 cases of CML using a dual-color, dual-fusion probe system with a third probe directed at 9q34. Cytogenetic studies showed a simple (typical) Ph in 124/152 (82%), a cryptic Ph in 11/152 (7%), and a variant Ph chromosome with a complex translocation in 17/152 (11%) of cases. Interphase FISH studies showed single BCR/ABL fusion patterns in 48/152 (32%) of cases. Deletions of 9q34 were observed in 14% of all the cases and were present in 46% of cases with single BCR/ABL fusion pattern. All the 9q34 deletions occurred in cases with single BCR/ABL fusion signal. However, a single-fusion pattern is not specific for 9q34 deletions, and cases should be routinely screened for the presence of this prognostically significant abnormality by using a third probe directed specifically at 9q34.

AB - Chronic myelogenous leukemia (CML) is characterized by the Philadelphia chromosome (Ph) in more than 90% of cases. Recent studies using fluorescence in situ hybridization (FISH) have shown that in a subset of patients with CML, deletions of 9q34 involving the argininosuccinate synthetase region occur at the time of the Philadelphia translocation and are associated with a poor prognosis. We performed interphase FISH studies in 152 cases of CML using a dual-color, dual-fusion probe system with a third probe directed at 9q34. Cytogenetic studies showed a simple (typical) Ph in 124/152 (82%), a cryptic Ph in 11/152 (7%), and a variant Ph chromosome with a complex translocation in 17/152 (11%) of cases. Interphase FISH studies showed single BCR/ABL fusion patterns in 48/152 (32%) of cases. Deletions of 9q34 were observed in 14% of all the cases and were present in 46% of cases with single BCR/ABL fusion pattern. All the 9q34 deletions occurred in cases with single BCR/ABL fusion signal. However, a single-fusion pattern is not specific for 9q34 deletions, and cases should be routinely screened for the presence of this prognostically significant abnormality by using a third probe directed specifically at 9q34.

UR - http://www.scopus.com/inward/record.url?scp=5144230626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5144230626&partnerID=8YFLogxK

U2 - 10.1016/j.cancergencyto.2004.02.012

DO - 10.1016/j.cancergencyto.2004.02.012

M3 - Article

VL - 154

SP - 138

EP - 143

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 2

ER -